Cost-Effectiveness Comparison of Salmeterol/Fluticasone Propionate versus Montelukast in the Treatment of Adults with Persistent Asthma

Author： Sheth K.  

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.20, Iss.13, 2002-01, pp. : 909-918

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cost Effectiveness of Fluticasone Propionate Plus Salmeterol Versus Fluticasone Propionate Plus Montelukast in the Treatment of Persistent Asthma

By Richard D. O’Connor  

PharmacoEconomics, Vol. 22, Iss. 12, 2004-01 ,pp. : 815-825

Adis International

Access to resources Recommend Favorite

Cost-Effectiveness and Cost-Utility of Beclomethasone/Formoterol versus Fluticasone Propionate/Salmeterol in Patients with Moderate to Severe Asthma

By Gerzeli Simone  

Clinical Drug Investigation, Vol. 32, Iss. 4, 2012-04 ,pp. : 253-265

Adis International

Access to resources Recommend Favorite

Salmeterol/fluticasone propionate cost effective in asthma

By  

Inpharma, Vol. 1, Iss. 1219, 2000-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Salmeterol/fluticasone propionate cost effective in asthma

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 358, 2002-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Salmeterol/fluticasone propionate more cost effective in asthma

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 487, 2005-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite